Vasiliki Sarli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Pharmaceutics

OncoTargets and therapy

Biomedicines

ACS pharmacology & translational science

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Apr 15o 2008

Greece

Associate Professor :: School of Chemistry

Publications

George Leonidis, Anastasia Koukiali, Ioanna Sigala, Katerina Tsimaratou, Dimitris Beis, Thomas Giannakouros, Eleni Nikolakaki, Vasiliki Sarli
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates. Pharmaceutics 15 (2) (2023)
George Leonidis, Anastasia Koukiali, Ioanna Sigala, Katerina Tsimaratou, Dimitris Beis, Thomas Giannakouros, Eleni Nikolakaki, Vasiliki Sarli
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates. Pharmaceutics 15 (2) (2023)
George Leonidis, Anastasia Koukiali, Ioanna Sigala, Katerina Tsimaratou, Dimitris Beis, Thomas Giannakouros, Eleni Nikolakaki, Vasiliki Sarli
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates. Pharmaceutics 15 (2) (2023)
George Leonidis, Anastasia Koukiali, Ioanna Sigala, Katerina Tsimaratou, Dimitris Beis, Thomas Giannakouros, Eleni Nikolakaki, Vasiliki Sarli
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates. Pharmaceutics 15 (2) (2023)
Maria Voura, Saleha Anwar, Ioanna Sigala, Eleftheria Parasidou, Souzanna Fragoulidou, M D Imtaiyaz Hassan, Vasiliki Sarli
Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors. ACS pharmacology & translational science 6 (7) (2023)
Eleni Sflakidou, George Leonidis, Eirini Foroglou, Christos Siokatas, Vasiliki Sarli
Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents. Molecules (Basel, Switzerland) 27 (19) (2022)
Sofia Sagredou, Panayiotis Dalezis, Eirini Papadopoulou, Maria Voura, Maria V Deligiorgi, Michail Nikolaou, Mihalis I Panayiotidis, George Nasioulas, Vasiliki Sarli, Dimitrios T Trafalis
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. Pharmaceutics 13 (6) (2021)
Nikolaos Nikoleousakos, Panayiotis Dalezis, Aikaterini Polonifi, Elena G Geromichalou, Sofia Sagredou, Constantinos E Alifieris, Maria V Deligiorgi, Vasiliki Sarli, Dimitrios T Trafalis
Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay. Biomedicines 9 (8) (2021)
Fani Tsitouroudi, Vasiliki Sarli, Dimitrios Poulcharidis, Maria Pitou, Alexandros Katranidis, Theodora Choli-Papadopoulou
Aza-Reversine Promotes Reprogramming of Lung (MRC-5) and Differentiation of Mesenchymal Cells into Osteoblasts. Materials (Basel, Switzerland) 14 (18) (2021)
Theodora Chatzisideri, George Leonidis, Theodoros Karampelas, Eleni Skavatsou, Angeliki Velentza-Almpani, Francesca Bianchini, Constantin Tamvakopoulos, Vasiliki Sarli
Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine. Journal of medicinal chemistry 65 (1) (2021)
Dimitrios T Trafalis, Sofia Sagredou, Panayiotis Dalezis, Maria Voura, Stella Fountoulaki, Nikolaos Nikoleousakos, Konstantinos Almpanakis, Maria V Deligiorgi, Vasiliki Sarli
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics 13 (4) (2021)
George Leonidis, Panagiotis Dalezis, Dimitrios Trafalis, Dimitris Beis, Panagiota Giardoglou, Anastasia Koukiali, Ioanna Sigala, Eleni Nikolakaki, Vasiliki Sarli
Synthesis and Biological Evaluation of a c(RGDyK) Peptide Conjugate of SRPIN803. ACS omega 6 (42) (2021)
Theodora Chatzisideri, Panayiotis Dalezis, George Leonidis, Spyridon Bousis, Dimitrios T Trafalis, Francesca Bianchini, Vasiliki Sarli
Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins. Future medicinal chemistry 13 (10) (2021)
Sofia Sagredou, Panayiotis Dalezis, Nikolaos Nikoleousakos, Michail Nikolaou, Maria Voura, Konstantinos Almpanakis, Mihalis I Panayiotidis, Vasiliki Sarli, Dimitrios T Trafalis
3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha. OncoTargets and therapy 13 (2020)

Vasiliki Sarli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vasiliki Sarli